rs143628723
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP3BP4_StrongBP6BS2
The NM_178335.3(CCDC50):c.1144G>A(p.Ala382Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000184 in 1,612,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
CCDC50
NM_178335.3 missense
NM_178335.3 missense
Scores
4
9
3
Clinical Significance
Conservation
PhyloP100: 6.08
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 5: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Dann [when max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.013216823).
BP6
Variant 3-191380834-G-A is Benign according to our data. Variant chr3-191380834-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 162859.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=2}.
BS2
High AC in GnomAd4 at 34 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC50 | NM_178335.3 | c.1144G>A | p.Ala382Thr | missense_variant | 9/12 | ENST00000392455.9 | |
CCDC50 | NM_174908.4 | c.616G>A | p.Ala206Thr | missense_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC50 | ENST00000392455.9 | c.1144G>A | p.Ala382Thr | missense_variant | 9/12 | 1 | NM_178335.3 | P3 | |
CCDC50 | ENST00000392456.4 | c.616G>A | p.Ala206Thr | missense_variant | 8/11 | 1 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 151988Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
34
AN:
151988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000412 AC: 103AN: 250238Hom.: 0 AF XY: 0.000429 AC XY: 58AN XY: 135310
GnomAD3 exomes
AF:
AC:
103
AN:
250238
Hom.:
AF XY:
AC XY:
58
AN XY:
135310
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000180 AC: 263AN: 1460634Hom.: 0 Cov.: 33 AF XY: 0.000190 AC XY: 138AN XY: 726612
GnomAD4 exome
AF:
AC:
263
AN:
1460634
Hom.:
Cov.:
33
AF XY:
AC XY:
138
AN XY:
726612
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000224 AC: 34AN: 151988Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74248
GnomAD4 genome
AF:
AC:
34
AN:
151988
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74248
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
34
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 11, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Oct 22, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jul 31, 2017 | The p.Ala382Thr variant (rs143628723) has not been previously associated with hearing loss, and is listed in the ClinVar database as a variant of uncertain significance (Variation ID: 162859). However, this variant is listed in the Genome Aggregation Database (gnomAD) browser with a frequency in Ashkenazi Jewish populations of 0.86% (identified in 87 out of 10,130 chromosomes). While the alanine at codon 382 is highly conserved (Alamut software v 2.8.1), due to similar physiochemical properties between alanine and the substituted threonine, computational analyses return mixed results regarding the effect of this variant on CCDC50 protein structure/function (SIFT: damaging, PolyPhen2: benign, and Mutation Taster: disease causing). This variant is not predicted to alter CCDC50mRNA splicing (Alamut software v 2.8.1). Pathogenic variants in CCDC50 are associated with an autosomal dominant form of hearing loss (MIM: 607453), and based on the ethnic specific population frequency of this variant, p.Ala382Thr is likely to be benign. - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 05, 2013 | Variant classified as Uncertain Significance - Favor Benign. The Ala382Thr varia nt in CCDC50 has not been reported in individuals with hearing loss, but has bee n identified in 0.05% (4/8458) of European American chromosomes in a broad popul ation by the NHLBI Exome sequencing project (http://evs.gs.washington.edu/EVS/; dbSNP rs143628723). Although this variant has been seen in the general populati on, its frequency is not high enough to rule out a pathogenic role. Computationa l analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen 2, and SIFT) do not provide strong support for or against an impact to the prote in. In summary, the clinical significance of this variant cannot be determined w ith certainty; however, based upon the its presence in the general population, w e would lean towards a more likely benign role. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.1144G>A (p.A382T) alteration is located in exon 9 (coding exon 9) of the CCDC50 gene. This alteration results from a G to A substitution at nucleotide position 1144, causing the alanine (A) at amino acid position 382 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
REVEL
Uncertain
Polyphen
P;D
MVP
MPC
0.61
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at